Mutational activation of ras genes is absent in pediatric osteosarcoma.
Activation of ras oncogenes is found in human cancers; overall it is observed in 15% of all neoplasms. The purpose of this study was to assess the extent of involvement of ras oncogenes in osteosarcoma. Tumor samples from a series of 49 pediatric patients diagnosed with osteosarcoma and treated at our institution were evaluated. Paraffin-embedded tumor samples from diagnostic biopsies, from tumor en bloc resection tissue after neoadjuvant chemotherapy, and samples from metastases were examined in search of point mutations in H, K, and N-ras genes at codons 12 and 61 by means of polymerase chain reaction (PCR), slot-blotting, and radioactive labeled specific DNA probes. A total of 92 archival samples were studied. No point mutations activating these genes were found. These findings suggest that the activation by point mutations at codons 12 and 61 of the H, K, and N-ras genes does not play a role in the pathogenesis of human osteosarcoma. Since no point mutations in codons 12 and 61 were detected, it was not possible to establish any correlation between the ras genes and clinical or histologic findings.
Department of Pediatrics, School of Medicine, Universidad de Navarra, Pamplona, Spain.
F
F
Antillón-Klüssmann
M
M
García-Delgado
I
I
Villa-Elízaga
L
L
Sierrasesúmaga
D001483:Base Sequence; D001859:Bone Neoplasms / Q000235:genetics*; D002648:Child; D004273:DNA, Neoplasm / Q000032:analysis; D011905:Genes, ras / Q000235:genetics*; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D012516:Osteosarcoma / Q000235:genetics*; D016133:Polymerase Chain Reaction
D004273:DNA, Neoplasm